A consortium of scientists, industry stakeholders, and patient advocacy leaders working together to promote advances in the diagnosis and treatment of leukodystrophies.
FEATURED
2026 Annual Report Spotlight
Discover how GLIA-CTN researchers, clinicians, patients, families, and advocacy partners are working together to advance research, improve diagnosis and treatment, and accelerate the development of new therapies for individuals affected by leukodystrophies.
Join one of our research studies
Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases.
Find a study
RDCRN Publishes First-Ever Annual Report
Read about research consortium achievements, early career investigators, patients and patient advocacy groups, and other network accomplishments.
Rare Research Report: June 2026
Each month, we share summaries of recent Rare Diseases Clinical Research Network grant-funded publications. Catch up on RDCRN research for June 2026.
Rare Research Report: May 2026
Each month, we share summaries of recent Rare Diseases Clinical Research Network grant-funded publications. Catch up on RDCRN research for May 2026.